Optimizing the Dutch newborn screening for congenital hypothyroidism by incorporating amino acids and acylcarnitines in a machine learning-based model.
acylcarnitines
amino acids
congenital hypothyroidism
machine learning based
newborn screening
Journal
European thyroid journal
ISSN: 2235-0802
Titre abrégé: Eur Thyroid J
Pays: England
ID NLM: 101604579
Informations de publication
Date de publication:
01 12 2023
01 12 2023
Historique:
received:
20
07
2023
accepted:
11
10
2023
medline:
6
11
2023
pubmed:
19
10
2023
entrez:
19
10
2023
Statut:
epublish
Résumé
Congenital hypothyroidism (CH) is an inborn thyroid hormone (TH) deficiency mostly caused by thyroidal (primary CH) or hypothalamic/pituitary (central CH) disturbances. Most CH newborn screening (NBS) programs are thyroid-stimulating-hormone (TSH) based, thereby only detecting primary CH. The Dutch NBS is based on measuring total thyroxine (T4) from dried blood spots, aiming to detect primary and central CH at the cost of more false-positive referrals (FPRs) (positive predictive value (PPV) of 21% in 2007-2017). An artificial PPV of 26% was yielded when using a machine learning-based model on the adjusted dataset described based on the Dutch CH NBS. Recently, amino acids (AAs) and acylcarnitines (ACs) have been shown to be associated with TH concentration. We therefore aimed to investigate whether AAs and ACs measured during NBS can contribute to better performance of the CH screening in the Netherlands by using a revised machine learning-based model. Dutch NBS data between 2007 and 2017 (CH screening results, AAs and ACs) from 1079 FPRs, 515 newborns with primary (431) and central CH (84) and data from 1842 healthy controls were used. A random forest model including these data was developed. The random forest model with an artificial sensitivity of 100% yielded a PPV of 48% and AUROC of 0.99. Besides T4 and TSH, tyrosine, and succinylacetone were the main parameters contributing to the model's performance. The PPV improved significantly (26-48%) by adding several AAs and ACs to our machine learning-based model, suggesting that adding these parameters benefits the current algorithm.
Identifiants
pubmed: 37855424
doi: 10.1530/ETJ-23-0141
pii: e230141
pmc: PMC10692681
doi:
pii:
Substances chimiques
Amino Acids
0
acylcarnitine
0
Thyrotropin
9002-71-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Neonatal Screen. 2021 Apr 23;7(2):
pubmed: 33922835
Pediatrics. 2005 Jul;116(1):168-73
pubmed: 15995048
J Clin Endocrinol Metab. 2018 Oct 1;103(10):3720-3728
pubmed: 30113641
Eur J Endocrinol. 2020 Sep;183(3):265-273
pubmed: 32580148
Orphanet J Rare Dis. 2010 Jun 10;5:17
pubmed: 20537182
Clin Biochem. 2023 Jun;116:7-10
pubmed: 36878346
BMC Med. 2017 Jan 9;15(1):6
pubmed: 28065164
Eur Thyroid J. 2021 Jun;10(3):222-229
pubmed: 34178708
Thyroid. 2017 Sep;27(9):1109-1117
pubmed: 28699427
Am J Med. 1966 Jun;40(6):823-7
pubmed: 5327670
Metabolomics. 2014;10(1):152-164
pubmed: 24955082
Eur Thyroid J. 2023 Jul 27;12(4):
pubmed: 37326450
Metabolism. 1977 Jun;26(6):665-718
pubmed: 67547
Best Pract Res Clin Endocrinol Metab. 2014 Mar;28(2):175-87
pubmed: 24629860
J Clin Endocrinol Metab. 2018 May 1;103(5):2050-2060
pubmed: 29546278
Gut. 1982 May;23(5):362-70
pubmed: 7076013
Bioinformatics. 2012 Jan 1;28(1):112-8
pubmed: 22039212
Clin Endocrinol (Oxf). 2021 Nov;95(5):766-781
pubmed: 34302303
JIMD Rep. 2020 May 13;54(1):68-78
pubmed: 32685353
J Clin Endocrinol Metab. 2008 Oct;93(10):3999-4005
pubmed: 18628521
Best Pract Res Clin Endocrinol Metab. 2007 Jun;21(2):237-51
pubmed: 17574006
J Pediatr. 1980 Oct;97(4):604-7
pubmed: 6775064
Thyroid. 2016 Oct;26(10):1422-1430
pubmed: 27465032
Hepatology. 2018 Jan;67(1):145-158
pubmed: 28802074
Physiol Rev. 2014 Apr;94(2):355-82
pubmed: 24692351